BTIG Adjusts OrthoPediatrics' Price Target to $68 From $75, Keeps Buy Rating
© MT Newswires 2021
All news about ORTHOPEDIATRICS CORP. |
|
|
|
Analyst Recommendations on ORTHOPEDIATRICS CORP. |
|
|
| |
|
Sales 2022 |
123 M
-
-
|
Net income 2022 |
-22,3 M
-
-
|
Net Debt 2022 |
-
-
-
|
P/E ratio 2022 |
-39,8x |
Yield 2022 |
- |
|
Capitalization |
918 M
918 M
-
|
Capi. / Sales 2022 |
7,49x |
Capi. / Sales 2023 |
6,30x |
Nbr of Employees |
133 |
Free-Float |
70,3% |
|
Chart ORTHOPEDIATRICS CORP.
Duration :
Period :
|

Technical analysis trends ORTHOPEDIATRICS CORP.
| Short Term | Mid-Term | Long Term | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
Mean consensus |
BUY |
Number of Analysts |
7 |
Last Close Price |
45,40 $ |
Average target price |
61,17 $ |
Spread / Average Target |
34,7% |
|